Coral's API range includes Corticosteroids, Antihistamines. Hormones and Antineoplastics.
01 2Coral Drugs Private Limited
02 1Axplora
03 1Seqens
04 1Aarti Pharmalabs
05 1TAPI Technology & API Services
06 1Amphastar Pharmaceuticals
07 1Apotex Pharmachem
08 2Aurisco Pharmaceutical
09 1Breathgreen Pharmaceuticals
10 3Cipla
11 1Curia
12 2GSK
13 2Hovione
14 1Industriale Chimica
15 1Lupin Ltd
16 1NEWCHEM SPA
17 1ScinoPharm Taiwan, Ltd
18 1Shandong Sito Bio-technology Co ltd
19 1Sterling Spa
20 1Sun Pharmaceutical Industries Limited
21 1Taro Pharmaceutical Industries
22 1Tianjin Tianyao Pharmaceuticals Co., Ltd.
23 1Viatris
01 9FLUTICASONE PROPIONATE
02 1FLUTICASONE PROPIONATE (CRUDE)
03 1FLUTICASONE PROPIONATE (PROCESS 1)
04 1FLUTICASONE PROPIONATE EP/BP
05 1FLUTICASONE PROPIONATE INHALATION GRADE
06 2FLUTICASONE PROPIONATE MICRONIZED
07 7FLUTICASONE PROPIONATE USP
08 1FLUTICASONE PROPIONATE USP (MICRONIZED)
09 1FLUTICASONE PROPIONATE USP (PROCESS II)
10 1FLUTICASONE PROPIONATE USP (PROCESS III)
11 1FLUTICASONE PROPIONATE USP/PH.EUR. (MICRONIZED)
12 1FLUTICASONE PROPIONATE(MICRONIZED AND NON-MICRONIZED)
13 1FLUTICASONE PROPIONATE, MICRONIZED
14 1FLUTICASONE PROPIONATE, USP
01 1Canada
02 4China
03 1France
04 1Germany
05 8India
06 1Israel
07 3Italy
08 2Portugal
09 1Taiwan
10 5U.S.A
11 2United Kingdom
01 26Active
02 3Inactive
01 16Complete
02 13Blank
GDUFA
DMF Review : Complete
Rev. Date : 2018-05-11
Pay. Date : 2018-04-10
DMF Number : 21879
Submission : 2008-08-12
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-02
Pay. Date : 2018-10-31
DMF Number : 20463
Submission : 2007-04-24
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2014-05-23
Pay. Date : 2014-05-05
DMF Number : 15456
Submission : 2001-05-24
Status : Active
Type : II
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-02
Pay. Date : 2013-03-11
DMF Number : 22980
Submission : 2009-07-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-30
Pay. Date : 2012-11-08
DMF Number : 15745
Submission : 2001-11-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36315
Submission : 2021-11-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-08-25
Pay. Date : 2014-08-14
DMF Number : 15774
Submission : 2001-12-19
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-15
Pay. Date : 2012-12-14
DMF Number : 16334
Submission : 2002-12-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-31
Pay. Date : 2014-10-20
DMF Number : 16423
Submission : 2003-02-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17618
Submission : 2004-08-20
Status : Active
Type : II
A Flixotide Inhaler manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flixotide Inhaler, including repackagers and relabelers. The FDA regulates Flixotide Inhaler manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flixotide Inhaler API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flixotide Inhaler manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flixotide Inhaler supplier is an individual or a company that provides Flixotide Inhaler active pharmaceutical ingredient (API) or Flixotide Inhaler finished formulations upon request. The Flixotide Inhaler suppliers may include Flixotide Inhaler API manufacturers, exporters, distributors and traders.
click here to find a list of Flixotide Inhaler suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Flixotide Inhaler DMF (Drug Master File) is a document detailing the whole manufacturing process of Flixotide Inhaler active pharmaceutical ingredient (API) in detail. Different forms of Flixotide Inhaler DMFs exist exist since differing nations have different regulations, such as Flixotide Inhaler USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Flixotide Inhaler DMF submitted to regulatory agencies in the US is known as a USDMF. Flixotide Inhaler USDMF includes data on Flixotide Inhaler's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Flixotide Inhaler USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Flixotide Inhaler suppliers with USDMF on PharmaCompass.
We have 23 companies offering Flixotide Inhaler
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?